A 4-microRNA Signature in Serum Can Discriminate Between Non-Small-Cell Lung Cancer and Malignant Pleural Mesothelioma

被引：0
|
作者：
Kirschner, M. [1 ]
Leygo, C. [2 ]
Burgers, S. [3 ]
Korse, T. [3 ]
Van Den Broek, D. [3 ]
Van Zandwijk, N. [2 ]
Reid, G. [2 ]
机构：
[1] Univ Hosp Zurich, Dept Thorac Surg, Zurich, Switzerland
[2] Asbestos Dis Res Inst, Sydney, NSW, Australia
[3] Netherlands Canc Inst, Amsterdam, Netherlands
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 11期
关键词：
MicroRNAs; NSCLC; Mesothelioma;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1.09-008
引用
收藏
页码：S2019 / S2020
页数：2
相关论文
共 50 条
  • [21] Emerging drugs for non-small-cell lung cancer
    Felip, Enriqueta
    Santarpia, Mariacarmela
    Rosell, Rafael
    EXPERT OPINION ON EMERGING DRUGS, 2007, 12 (03) : 449 - 460
  • [22] Establishment and validation of a 7-microRNA prognostic signature for non-small cell lung cancer
    Wang, Nan
    Guo, Huihui
    Dong, Zhaohuo
    Chen, Qiuqiang
    Zhang, Xilin
    Shen, Weiyun
    Bao, Ying
    Wang, Xiang
    CANCER MANAGEMENT AND RESEARCH, 2018, 10 : 3463 - 3471
  • [23] Serum exosomal microRNAs as predictive markers for EGFR mutations in non-small-cell lung cancer
    Xia, Junbo
    Luo, Man
    Dai, Lujun
    Wang, Liusheng
    Wang, Limin
    Zhu, Jing
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2021, 35 (05)
  • [24] Immunotherapy in non-small-cell lung cancer: a bridge between research and clinical practice
    Francesco, Passiglia
    Oriana, Commendatore
    Milena, Vitali
    Raffaele, Conca
    FUTURE ONCOLOGY, 2018, 14 (13) : 41 - 60
  • [25] Correlation between nivolumab exposure and treatment outcomes in non-small-cell lung cancer
    Basak, Edwin A.
    Koolen, Stijn L. W.
    Hurkmans, Daan P.
    Schreurs, Marco W. J.
    Bins, Sander
    Oomen-de Hoop, Esther
    Wijkhuijs, Annemarie J. M.
    den Besten, Ilse
    Sleijfer, Stefan
    Debets, Reno
    van der Veldt, Astrid A. M.
    Aerts, Joachim G. J., V
    Mathijssen, Ron H. J.
    EUROPEAN JOURNAL OF CANCER, 2019, 109 : 12 - 20
  • [26] Therapeutic cancer vaccines in the treatment of non-small-cell lung cancer
    Limacher, Jean-Marc
    Spring-Giusti, Clementine
    Bellon, Nadine
    Ancian, Philippe
    Rooke, Ronald
    Bonnefoy, Jean-Yves
    EXPERT REVIEW OF VACCINES, 2013, 12 (03) : 263 - 270
  • [27] Epiregulin as a therapeutic target in non-small-cell lung cancer
    Sunaga, Noriaki
    Kaira, Kyoichi
    LUNG CANCER-TARGETS AND THERAPY, 2015, 6 : 91 - 98
  • [28] Immunotherapy in advanced non-small-cell lung cancer withEGFRmutations
    Liu, Fangfang
    Yuan, Xun
    Jiang, Jizong
    Chu, Qian
    IMMUNOTHERAPY, 2020, 12 (16) : 1195 - 1207
  • [29] Gemcitabine: A reality in the treatment of non-small-cell lung cancer
    Rinaldi, M
    TUMORI, 1997, 83 (06) : S3 - S7
  • [30] Targeting tumor neovasculature in non-small-cell lung cancer
    Pallis, Athanasios G.
    Syrigos, Konstantinos N.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2013, 86 (02) : 130 - 142
12345